In Brief This Week: Pacific Biosciences; GeneNews; Pathwork Diagnostics; Proteros Biostructures | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences has been added to the Nasdaq Biotechnology Index.

Nasdaq's semi-annual re-ranking has resulted in six firms being added to the Biotech Index, though PacBio is the only life science tools firm among the new members. The new Index is effective prior to market open on Monday, May 23.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.